REG - Intnl. Biotechnology - Block listing Interim Review

International Biotechnology TrustAnnouncement

Thu 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250703:nRSC6800Pa&default-theme=true

RNS Number : 6800P  Intl. Biotechnology Trust PLC  03 July 2025

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

(Note: Italicised terms have the same meaning as given in the UK Listing
Rules.)

Date: 3 July 2025

 

 Name of applicant:                                                                International Biotechnology Trust plc
 Name of scheme:                                                                   Block listing for general business purposes
 Period of return:                        From:                                    4 January 2025   To:              3 July 2025
 Balance of unallotted securities under scheme(s) from previous return:            4,712,694
 Plus:  The amount by which the block scheme(s) has been increased since the       +0
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         -0
 (see UKLR 20.6.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        4,712,694

 

 Name of contact:              Kerry Higgins

                               Schroder Investment Management Limited
 Telephone number of contact:  020 7658 6189

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRUPUGCMUPAGAW